Cargando…

A high molar activity (18)F-labeled TAK-875 derivative for PET imaging of pancreatic β-cells

BACKGROUND: The free-fatty acid receptor-1 (FFA-1) is expressed by β-cells and is a promising target for molecular imaging of functional β-cell mass. Recently, the ((3-[(18)F]fluoropropyl)sulfonyl)propoxy-derivative of the high-affinity FFA-1 agonist TAK-875 ([(18)F]7) was reported. Here we describe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dornan, Mark H., Petrenyov, Daniil, Simard, José-Mathieu, Aliaga, Antonio, Xiong, Guoming, Ghislain, Julien, Bedell, Barry, Poitout, Vincent, DaSilva, Jean N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301904/ http://dx.doi.org/10.1186/s41181-018-0051-2

Ejemplares similares

Synthesis of a (11)C-Isotopologue of the B-Raf-Selective Inhibitor Encorafenib Using In-Loop [(11)C]CO(2) Fixation
por: Dornan, Mark H., et al.
Publicado: (2020)

A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
por: Yabuki, Chiori, et al.
Publicado: (2013)

Synthesis of the Novel AT(1) Receptor Tracer [(18)F]Fluoropyridine–Candesartan via Click Chemistry
por: Abreu Diaz, Aida M., et al.
Publicado: (2020)

Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus
por: Naik, H, et al.
Publicado: (2013)

Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver Injury
por: Wolenski, Francis S., et al.
Publicado: (2017)

TAK-875 Mitigates β-Cell Lipotoxicity-Induced Metaflammation Damage through Inhibiting the TLR4-NF-κB Pathway
por: Chen, Xide, et al.
Publicado: (2019)

Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury
por: Longo, Diane M, et al.
Publicado: (2019)

Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes
por: Kaku, Kohei, et al.
Publicado: (2013)

Late‐Stage (18)F‐Difluoromethyl Labeling of N‐Heteroaromatics with High Molar Activity for PET Imaging
por: Trump, Laura, et al.
Publicado: (2019)

Fasiglifam (TAK‐875) has dual potentiating mechanisms via Gαq‐GPR40/FFAR1 signaling branches on glucose‐dependent insulin secretion
por: Sakuma, Kensuke, et al.
Publicado: (2016)

Correction to Lancet Psychiatry 2020; 7: 875–82
Publicado: (2020)

Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans
por: Maachi, Hasna, et al.
Publicado: (2021)

Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner
por: Kim, MinJeong, et al.
Publicado: (2018)

875 Prospective Monitoring of Indwelling Urinary Catheters in Hospitalized Patients
por: Yoon, Bona, et al.
Publicado: (2014)

Brain endothelial TAK1 and NEMO safeguard the neurovascular unit
por: Ridder, Dirk A., et al.
Publicado: (2015)

875. Sex Differences in Academic Achievement and Faculty Rank in Academic Infectious Diseases
por: Manne-Goehler, Jennifer, et al.
Publicado: (2018)

High molar activity [(18)F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
por: Soloviev, Dmitry, et al.
Publicado: (2022)

Fluorine-18 Labelled Radioligands for PET Imaging of Cyclooxygenase-2
por: Kaur, Jatinder, et al.
Publicado: (2022)

Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
por: Kaku, K, et al.
Publicado: (2015)

875. Pseudo-outbreak of Clostridioides (Clostridium) difficile amongst post-operative Oncology Patients
por: Kagedan, Daniel, et al.
Publicado: (2020)

A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events
por: Dhanda, Sandeep, et al.
Publicado: (2021)

875. Development of a Cheap, Portable Assay to Rapidly Profile Resistant Bacterial Infections
por: Roach, David, et al.
Publicado: (2023)

TAK1ng control: TAK1 restrains NLRP3 activation
por: Mangan, Matthew Stephen, et al.
Publicado: (2018)

Fluorine-18 labeled amino acids for tumor PET/CT imaging
por: Qi, Yiqiang, et al.
Publicado: (2017)

The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice
por: Fontés, Ghislaine, et al.
Publicado: (2015)

(18) F-click labeling and preclinical evaluation of a new (18) F-folate for PET imaging
por: Schieferstein, Hanno, et al.
Publicado: (2013)

Simplified one-pot (18)F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity
por: Yang, Hongzhang, et al.
Publicado: (2023)

Ten Years of Operative Surgery in the Provinces: Being the Record of 875 Operations, Performed from 1850 to 1860
Publicado: (1865)

Single-crystal-to-single-crystal phase transitions of commensurately modulated sodium saccharinate 1.875-hydrate
por: Rekis, Toms, et al.
Publicado: (2021)

On the puzzling case of sodium saccharinate 1.875-hydrate: structure description in (3+1)-dimensional superspace
por: Rekis, Toms, et al.
Publicado: (2020)

Erratum to “Long COVID: An overview” [Diabetes Metabol. Syndr. Clin. Res. Rev. (2021) 869–875]
por: Raveendran, A.V., et al.
Publicado: (2022)

A new F-18 labeled PET tracer for fatty acid imaging
por: Demeure, Fabian, et al.
Publicado: (2014)

PET imaging of HER2 expression with an (18)F-fluoride labeled aptamer
por: Kim, Hyun Jeong, et al.
Publicado: (2019)

PET of HER2 Expression with a Novel (18)FAl Labeled Affibody
por: Xu, Yuping, et al.
Publicado: (2017)

Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
por: Syvänen, Stina, et al.
Publicado: (2020)

Development of (18)F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging
por: García-Vázquez, Rocío, et al.
Publicado: (2022)

lncRNA HOXB-AS3 protects doxorubicin-induced cardiotoxicity by targeting miRNA-875-3p
por: Lu, Qun, et al.
Publicado: (2020)

Erratum: The Role of Plasticity and Adaptation in the Incipient Speciation of a Fire Salamander Population (Genes 2019, 10, 875)
por: Sabino-Pinto, Joana, et al.
Publicado: (2020)

Comprehensive genome analysis of Burkholderia contaminans SK875, a quorum-sensing strain isolated from the swine
por: Kim, Eiseul, et al.
Publicado: (2023)

PET Imaging of Integrin Positive Tumors Using (18)F Labeled Knottin Peptides
por: Liu, Shuanglong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jcc6sg84im8b6vpmql0rjb6p42